Search

ANI Pharmaceuticals Inc

Open

SectorHealthcare

74.98 1.7

Overview

Share price change

24h

Current

Min

73.05

Max

74.76

Key metrics

By Trading Economics

Income

-655K

27M

Sales

29M

266M

P/E

Sector Avg

16.558

57.371

EPS

1.82

Profit margin

10.064

Employees

970

EBITDA

3M

60M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+49.43% upside

Dividends

By Acuity

Next Earnings

6 Nov 2026

Market Stats

By TradingEconomics

Market Cap

-74M

1.7B

Previous open

73.28

Previous close

74.98

News Sentiment

By Acuity

55%

45%

286 / 340 Healthcare

ANI Pharmaceuticals Inc Chart

Past performance is not a reliable indicator of future results.

Related News

24 Aug 2026, 20:13 UTC

ANI Pharmaceuticals Inc. shares are higher in after-market trading, recovering from four consecutive sessions of losses amid ongoing geopolitical concerns.

21 Aug 2026, 20:01 UTC

ANI Pharmaceuticals Inc. shares are lower today, continuing a decline since Thursday's close and trading near the lower end of its one-month range.

20 Aug 2026, 19:46 UTC

ANI Pharmaceuticals is trading lower today, having peaked earlier in the session. The stock remains below its 20-day moving average amid strong labor market data.

19 Aug 2026, 23:41 UTC

ANI Pharmaceuticals Inc. shares declined after-market, falling sharply below the 20-day moving average and near the lower end of their one-month trading range.

18 Aug 2026, 20:12 UTC

ANI Pharmaceuticals shares are higher in after-market trading, despite no specific news. The asset remains near the lower end of its one-month range.

17 Aug 2026, 19:36 UTC

News

ANI Pharmaceuticals reports $266 million in Q2 revenue, exceeding estimates. However, shares are lower amid guidance concerns and broader market declines.

14 Aug 2026, 19:26 UTC

ANI Pharmaceuticals is trading higher, recovering from an early drop amid broader market concerns following a decline in U.S. retail sales for July.

13 Aug 2026, 22:16 UTC

ANI Pharmaceuticals Inc. shares showed routine trading activity in after-market hours, remaining roughly flat since Thursday's close and near the lower end of its one-month range.

12 Aug 2026, 19:36 UTC

ANI Pharmaceuticals Inc shares are higher during Wednesday's session amid a broader market optimism following a modest increase in inflation data.

11 Aug 2026, 19:56 UTC

News

ANI Pharmaceuticals shares are lower despite a 25.9% sales increase to $266 million. Full-year revenue guidance of $1.11 billion fell short of estimates.

10 Aug 2026, 20:01 UTC

News

ANI Pharmaceuticals shares are lower today as analysts cut price targets, despite strong Q2 earnings that exceeded estimates and revenue growth.

7 Aug 2026, 20:03 UTC

News

ANI Pharmaceuticals shares are lower after reporting Q2 revenue of $266 million and providing full-year guidance of $1.11 billion, below analyst estimates.

6 Aug 2026, 19:51 UTC

News

ANI Pharmaceuticals shares are rising amid high trading volume ahead of its Q2 earnings report. Analysts expect revenue growth to decelerate compared to last year.

5 Aug 2026, 20:06 UTC

ANI Pharmaceuticals Inc shares are higher today, though no specific news explains the move. Market sentiment has improved amid a decline in crude oil prices.

4 Aug 2026, 19:33 UTC

News

ANI Pharmaceuticals is declining today despite noted revenue growth and improved cash flow margins, as sector regulation raises caution about earnings potential.

3 Aug 2026, 19:46 UTC

ANI Pharmaceuticals is trading higher since Friday's close, despite a flat overall session. The stock remains near the lower end of its one-month range.

31 Jul 2026, 20:06 UTC

ANI Pharmaceuticals Inc. shares are declining amid unusual volatility, with trading lower since Thursday as inflation concerns rise alongside US Treasury yields and crude oil prices.

30 Jul 2026, 20:09 UTC

ANI Pharmaceuticals Inc. shares are lower during Thursday's session, following a notable dip in late morning trading amid mixed economic signals impacting broader market conditions.

29 Jul 2026, 19:19 UTC

ANI Pharmaceuticals shares are higher, rebounding after an earlier pullback. Market sentiment is influenced by expectations for the Federal Reserve's monetary policy announcement today.

28 Jul 2026, 20:02 UTC

ANI Pharmaceuticals is advancing today, continuing an upward trend since Monday, despite declines in broader market sectors, particularly technology stocks in Asia.

24 Jul 2026, 20:06 UTC

News

ANI Pharmaceuticals shares are lower today amid mixed market sentiment for healthcare stocks. The company plans to discuss its Q2 2026 financial results on August 7, 2026.

22 Jul 2026, 20:01 UTC

News

Shares of ANI Pharmaceuticals are lower amid concerns over potential tariffs on imported generic drugs. The stock is near the lower end of its one-month range.

21 Jul 2026, 20:12 UTC

ANI Pharmaceuticals Inc. shares are lower in after-market trading, positioned below the 20-day moving average and near the lower end of their one-month range.

20 Jul 2026, 19:46 UTC

News
Social Media

ANI Pharmaceuticals shares are lower despite positive results from the Phase 4 SYNCHRONICITY trial, which may support expanded use of ILUVIEN.

Peer Comparison

Price change

ANI Pharmaceuticals Inc Forecast

Price Target

By TipRanks

49.43% upside

12 Months Forecast

Average 110.83 USD  49.43%

High 121 USD

Low 90 USD

Based on 6 Wall Street analysts offering 12 month price targets forANI Pharmaceuticals Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

6 ratings

5

Buy

1

Hold

0

Sell

Sentiment

By Acuity

286 / 340 Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About ANI Pharmaceuticals Inc

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
help-icon Live chat